141 related articles for article (PubMed ID: 36308387)
1. Association between Serum Progastrin Biomarker Level and Gastric Cancer.
Amjadi O; Alizadeh-Navaei R; Rezapour M; Omrani-Nava V; Moosazadeh M; Azadeh H; Zaboli E; Ahmadi M; Hedayatizadeh-Omran A
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3595-3599. PubMed ID: 36308387
[TBL] [Abstract][Full Text] [Related]
2. Serum progastrin and its products, gastric acid secretion and serum pepsinogen I in gastric cancer.
Konturek SJ; Konturek PC; Bielanski W; Karczewska E; Zuchowicz M; Hartwich A; Rehfeld JF; Goetze JP; Hahn EG
Digestion; 2003; 68(4):169-77. PubMed ID: 14671424
[TBL] [Abstract][Full Text] [Related]
3. Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients.
Konturek PC; Konturek SJ; Bielanski W; Kania J; Zuchowicz M; Hartwich A; Rehfeld JF; Hahn EG
Dig Dis Sci; 2003 Oct; 48(10):2005-17. PubMed ID: 14627349
[TBL] [Abstract][Full Text] [Related]
4. Significance of Serum Apelin Levels as a Biomarker for Gastric Cancer Diagnosis.
Hedayatizadeh-Omran A; Shekarriz R; Amjadi O; Alizadeh-Navaei R; Babamohammadi S
Asian Pac J Cancer Prev; 2023 Mar; 24(3):827-831. PubMed ID: 36974534
[TBL] [Abstract][Full Text] [Related]
5. Effects of cyclooxygenase-2 inhibition on serum and tumor gastrins and expression of apoptosis-related proteins in colorectal cancer.
Konturek PC; Rembiasz K; Burnat G; Konturek SJ; Tusinela M; Bielanski W; Rehfeld J; Karcz D; Hahn E
Dig Dis Sci; 2006 Apr; 51(4):779-87. PubMed ID: 16615003
[TBL] [Abstract][Full Text] [Related]
6. Progastrin and cyclooxygenase-2 in colorectal cancer.
Konturek PC; Bielanski W; Konturek SJ; Hartwich A; Pierzchalski P; Gonciarz M; Marlicz K; Starzynska T; Zuchowicz M; Darasz Z; Götze JP; Rehfeld JF; Hahn EG
Dig Dis Sci; 2002 Sep; 47(9):1984-91. PubMed ID: 12353842
[TBL] [Abstract][Full Text] [Related]
7. A new biomarker that predicts colonic neoplasia outcome in patients with hyperplastic colonic polyps.
Do C; Bertrand C; Palasse J; Delisle MB; Shulkes A; Cohen-Jonathan-Moyal E; Ferrand A; Seva C
Cancer Prev Res (Phila); 2012 Apr; 5(4):675-84. PubMed ID: 22366915
[TBL] [Abstract][Full Text] [Related]
8. Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients.
Li L; Yin X; Meng H; Hu J; Yu Z; Xu J
Yonsei Med J; 2020 Jan; 61(1):15-19. PubMed ID: 31887795
[TBL] [Abstract][Full Text] [Related]
9. Progastrin: a potential predictive marker of liver metastasis in colorectal cancer.
Westwood DA; Patel O; Christophi C; Shulkes A; Baldwin GS
Int J Colorectal Dis; 2017 Jul; 32(7):1061-1064. PubMed ID: 28432443
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of N-terminal progastrin fragments on gastric acid secretion in man.
Goetze JP; Hansen CP; Rehfeld JF
Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28275110
[TBL] [Abstract][Full Text] [Related]
11. Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.
Boroumand-Noughabi S; Sima HR; Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Hosseinnezhad H; Moaven O; Rajabi-Mashhadi MT; Azarian AA; Mashhadinejad M; Tavakkol-Afshari J
BMC Cancer; 2010 Jun; 10():275. PubMed ID: 20534173
[TBL] [Abstract][Full Text] [Related]
12. Progastrin in serum from Zollinger-Ellison patients. An indicator of malignancy?
Bardram L
Gastroenterology; 1990 Jun; 98(6):1420-6. PubMed ID: 2338186
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma.
Siddheshwar RK; Gray JC; Kelly SB
Gut; 2001 Jan; 48(1):47-52. PubMed ID: 11115822
[TBL] [Abstract][Full Text] [Related]
14. Progastrin: An Overview of Its Crucial Role in the Tumorigenesis of Gastrointestinal Cancers.
Fioretzaki R; Sarantis P; Charalampakis N; Christofidis K; Mylonakis A; Koustas E; Karamouzis MV; Sakellariou S; Schizas D
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672239
[TBL] [Abstract][Full Text] [Related]
15. Characterization of gastrins and their receptor in solid human gastric adenocarcinomas.
Goetze JP; Eiland S; Svendsen LB; Vainer B; Hannibal J; Rehfeld JF
Scand J Gastroenterol; 2013 Jun; 48(6):688-95. PubMed ID: 23544442
[TBL] [Abstract][Full Text] [Related]
16. Serum chemokine ligand 5 (CCL5/RANTES) level might be utilized as a predictive marker of tumor behavior and disease prognosis in patients with gastric adenocarcinoma.
Sima AR; Sima HR; Rafatpanah H; Hosseinnezhad H; Ghaffarzadehgan K; Valizadeh N; Mehrabi Bahar M; Hakimi HR; Masoom A; Noorbakhsh A; Razavi Satvati N; Raziee HR
J Gastrointest Cancer; 2014 Dec; 45(4):476-80. PubMed ID: 25301002
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of recombinant progastrin in sheep.
Paterson AC; Baldwin GS; Shulkes A
Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E449-56. PubMed ID: 12169437
[TBL] [Abstract][Full Text] [Related]
18. Processing and proliferative effects of human progastrin in transgenic mice.
Wang TC; Koh TJ; Varro A; Cahill RJ; Dangler CA; Fox JG; Dockray GJ
J Clin Invest; 1996 Oct; 98(8):1918-29. PubMed ID: 8878444
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of chromogranin A versus gastrin and progastrin in gastrinoma diagnosis and control.
Rehfeld JF; Bardram L; Hilsted L; Goetze JP
Biomark Med; 2014; 8(4):571-80. PubMed ID: 24796622
[TBL] [Abstract][Full Text] [Related]
20. High serum MMP-14 predicts worse survival in gastric cancer.
Kasurinen A; Tervahartiala T; Laitinen A; Kokkola A; Sorsa T; Böckelman C; Haglund C
PLoS One; 2018; 13(12):e0208800. PubMed ID: 30532247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
